EASD 2025 15 - 19 September 2025

Efficacy and hypoglycaemia outcomes with once-weekly IcoSema vs comparators in type 2 diabetes according to pre-trial sodium-glucose cotransporter-2 inhibitor use: a post hoc analysis of COMBINE 1–3

Authors :

Linong Ji¹; Jonas Dahl Andersen²; Sofie Bech Andersen³; Laura Pletsch-Borba³; Viswanathan Mohan⁴; Daisuke Yabe⁵

Affiliations

View Details Hide Details

Keywords

Diabetes

Congress short oral presentation

Insulin

IcoSema (Icodec Semaglutide)

PHASE 3 (RCT)

Are you a healthcare professional?